Following the British HIV Association’s (BHIVA) proposal of ambitious targets for eliminating hepatitis C in people living with HIV in the UK, a new editorial in The Lancet looks at some the benefits of microelimination strategies. “Focusing elimination efforts in smaller affected populations allows for quick, efficient targeting of treatment and prevention services,” the article…